Laman UtamaRGLS • NASDAQ
add
Regulus Therapeutics Inc
Tutup sebelumnya
$2.01
Julat hari
$2.01 - $2.14
Julat tahun
$0.83 - $2.90
Permodalan pasaran
139.77J USD
Bilangan Purata
1.83J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | -19.51J | -59.75% |
Pendapatan bersih | -12.79J | -58.68% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.20 | 50.00% |
EBITDA | -13.66J | -66.09% |
Kadar cukai berkesan | 0.00% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 75.78J | 218.83% |
Jumlah aset | 84.18J | 173.76% |
Jumlah liabiliti | 7.77J | -18.72% |
Jumlah ekuiti | 76.41J | — |
Syer tertunggak | 66.24J | — |
Harga kepada buku | 1.72 | — |
Pulangan pada aset | -38.62% | — |
Pulangan pada modal | -41.53% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -12.79J | -58.68% |
Tunai daripada operasi | -11.84J | -93.39% |
Tunai daripada pelaburan | 24.00J | 386.62% |
Tunai daripada pembiayaan | 0.00 | 100.00% |
Perubahan bersih dalam tunai | 12.16J | 688.33% |
Aliran tunai bebas | -7.24J | -119.86% |
Perihal
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia
Diasaskan
Sep 2007
Tapak web
Pekerja
34
